Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 3217
Selected: 0
NCT IDTitle
NCT03128866Tranexamic Acid in Reducing Blood Loss in Patients With Pelvic Tumors Undergoing Hemipelvectomy Surgery
NCT00528502Lidocaine Supplement for Minimal Invasive Parathyroid Surgery
NCT04633902Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) Mutation
NCT03541902Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma
NCT03263572Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia
NCT01808677Registry Study of Thoracic Reirradiation for Non-Small Cell Lung Cancer (NSCLC) Utilizing Proton Beam Therapy or Intensity Modulated Radiation Therapy
NCT01208662Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65
NCT06257888A Prospective Cohort With Patient Navigation as an Intervention for Breast Cancer Patients
NCT04404088Acalabrutinib, Lenalidomide, and Rituximab for the Treatment of CD20 Positive Stage III-IV, Grade 1-3a Follicular Lymphoma
NCT01090388Bladder Cancer Patient-Reported Outcomes
NCT00515788DepoCyt Plus Temozolomide in Patients With Neoplastic Meningitis
NCT04132505Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic Cancer
NCT02018653CASAD for Severe Diarrhea in the Emergency Department
NCT02530437Taladegib, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Localized Esophageal or Gastroesophageal Junction Cancer
NCT07136077A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy
NCT03070301A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors
NCT01750983Ipilimumab and Lenalidomide in Advanced Cancer
NCT04047641Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
NCT00458354Use of Spinal Sealant System During Spinal Surgery
NCT00221039Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A
NCT06815354Comprehensive Assessment of Cancer Theranostic Response
NCT02295956Preoperative Rehabilitation During Neoadjuvant Therapy for Pancreatic Cancer
NCT03367156Dexamethasone in Controlling Dyspnea in Patients With Cancer
NCT00500422Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients
NCT02167295Biobehavioral and Cultural Determinants of Betel Quid Chewing, Dependence, and Withdrawal in Taiwan
NCT00980239HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver
NCT00448019FCR and Bevacizumab in the Treatment of Relapsed Chronic Lymphocytic Leukemia (CLL)
NCT01073267Study of Total Skin Electron Beam Therapy (TSEBT) in Stage IB-IIIA Mycosis Fungoides
NCT05761951Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer
NCT00510653Gleevec Study for Patients With Ovarian Cancer
NCT00511641Quality of Life Associated With a Low-Risk Screening Program for Ovarian Cancer
NCT04751422Medical Data Collection for the Evaluation of Radiofrequency Ablation and Cement Augmentation for the Treatment of Secondary Metastases to the Spine
NCT00529022Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer
NCT00533338Weight Gain Prevention for Breast Cancer Survivors
NCT00566618Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis
NCT00003048Amifostine in Treating Patients With Myelodysplastic Syndrome
NCT05053555High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
NCT02861417Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
NCT02043158Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer
NCT02096055Guadecitabine With or Without Idarubicin or Cladribine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
NCT02891447Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal Cancer
NCT02394535Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic Cancer
NCT00502125In Vivo Confocal Imaging of Oral Mucosa
NCT00429117Interest in Spirituality and Oncology: Is It An International Phenomenon?
NCT01375140Ruxolitinib and Lenalidomide for Patients With Myelofibrosis
NCT06548230A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
NCT03587662Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
NCT03207542Trial Evaluating the Efficacy and Safety of Daratumumab in Subjects With Relapsed/Refractory B-cell or T-cell Precursor Acute Lymphoblastic Leukemia (ALL)
NCT01952054Denosumab for Breast Cancer With Bone Mets
NCT03136146Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia